CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 77 enrolled
Drug / intervention
Adaptive Radiation Therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02460835
NCT02460835N/ACompleted

A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma

University of Michigan Rogel Cancer Center·interventional·Posted Jun 2, 2015·Updated Nov 15, 2023

In Brief

A clinical study evaluating Adaptive Radiation Therapy for Hepatocellular Carcinoma. Completed, enrolled 77 participants across 1 site.

Detailed Summary

This is a pilot single arm study with the primary endpoints of feasibility and preliminary estimates of safety and efficacy. This protocol builds on over 25 years of experience with high dose liver RT (Radiation Therapy), and in particular adaptive RT aimed at adjusting the global radiation dose based on a patient's measured sensitivity to treatment. This current protocol uses functional imaging and specialized radiation planning techniques to spare highly functional portions of the liver to preserve function. The investigators feel this will further improve the safety and efficacy of RT for all patients by customizing treatments to each. If this approach is promising, the investigators will proceed to a phase II randomized study of standard versus spatially and dosimetrically adapted RT.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 2, 2015
Enrollment StartJan 26, 2016
Primary CompletionJan 20, 2022
TodayJul 2, 2026
Enrollment to primary: 6.0 yearsPosted 11.1 years ago

Interventions

Adaptive Radiation Therapyradiation